HIGHLIGHTS
- who: Wuhan Yu and collaborators from the The Second Hospital of Lanzhou University, Lanzhou, China have published the research work: EZH2: An Accomplice of Gastric Cancer, in the Journal: Cancers 2023, 425 of /2023/
- what: EZH2 is highly expressed in GC, which has been proven to be associated with poor prognosis in GC.
- how: The results showed that EZH2 SNPs were associated with susceptibility to GC the depth of primary tumor invasion and lymph node metastasis which was consistent with the findings of Sun et_al . The results showed that these two highly expressed . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.